title: Response to: 'Evaluation of the association between anticarbamylated protein antibodies and longitudinal course of functional ability in rheumatoid arthritis' by Ajeganova et al.
authors.affiliation: Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK.
authors.forename: J H
authors.initials: JH
authors.lastname: Humphreys
authors.affiliation: Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, UK.
authors.forename: D P M
authors.identifier: http://orcid.org/0000-0002-8625-1200
authors.initials: DP
authors.lastname: Symmons
authors.affiliation: Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK.
authors.forename: S M M
authors.initials: SM
authors.lastname: Verstappen
mesh_terms: D001172:Arthritis, Rheumatoid / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D002219:Carbamates / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D001323:Autoantibodies; D002219:Carbamates
keywords: Inflammation; Rheumatoid Arthritis; Treatment